Vanberra Signal

Biostate

Curated by Signal

Developer of generative AI based RNAstate research platform to predict future omics states

Overview

Developer of generative AI based RNAstate research platform to predict future omics states with temporal precision. It uses artificial intelligence to provide analytics, insights, and visualization, to facilitate publications or lead optimization decisions, enabling research organizations to get insightful bioinformatic data analysis. It uses barcode integrated reverse transcription to analyze types of RNA, including non coding RNA species. The platform RNA sequencing and analysis tools technology helps researchers understanding of gene expression and regulation, leading to insights into the mechanisms of disease and therapeutic targets.

Key facts

Founded
2023

Business model

Contact

More on Vanberra Signal

Members only

Competitors & similar companies

More Health Technology companies
  • Provider of wearable continuous blood pressure monitoring device

    Health TechnologySan Diego, United States
  • Digital health monitoring tool for providers

    Health TechnologyMenlo Park, United States
  • Digital platform that connects senior members with caregivers

    Health TechnologyMiami, United States

About Biostate

What does Biostate do?

Developer of generative AI based RNAstate research platform to predict future omics states with temporal precision.

Where is Biostate headquartered?

Biostate is headquartered in Houston, United States.

When was Biostate founded?

Biostate was founded in 2023.

Which sector is Biostate in?

Biostate operates in Health Technology.

Who are Biostate's competitors?

Companies similar to Biostate include Curescendo, DigitoHealth, and Papa.